Steven Horwitz on valemetostat for relapsed or refractory T-cell lymphoma October 30, 2024 • The Lancet Group

https://thelancetoncology.buzzsprout.com/1391338/episodes/15968635-steven-horwitz-on-valemetostat-for-relapsed-or-refractory-t-cell-lymphoma?utm_campaign=update-lanonc&utm_medium=email&_hsenc=p2ANqtz-_lDgisKvfXcYQbdk_gbef_5yg_02nU17S0c_uqj1lNLlKbvzBkgKhPIp0tJhfKYqZLjEToeqCq1QnKvvOD7D8ZCbYSqw&_hsmi=333363116&utm_content=333359314&utm_source=hs_email